Julia Haller is a Retinal Diseases and Treatments physician affiliated with Wills Eye Hospital. OpenAlex indexes 505 publications with 22,085 citations (h-index 71); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Ophthalmology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Julia Haller, M.D., is affiliated with Wills Eye Hospital. The public record shows 505 publications with 22,085 citations (h-index 71), centered on Retinal Diseases and Treatments, Retinal and Macular Surgery, Retinal and Optic Conditions. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 7 companies, 2 NIH-funded awards (2010–2018).
- Most recent indexed publication: 2022 · Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
- Top research focus: Retinal Diseases and Treatments
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 259.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
Sponsor: Wills Eye
- Electric Stimulation of the Eye to Improve Vision After Trauma
Sponsor: Wills Eye
Industry payments
Updated 27 Aug 2026
7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Bristol Myers Squibb CompanyProgram year202573 payments$273,500openpaymentsdata.cms.gov ↗
- Bausch & Lomb Americas Inc.Program year202510 payments
- Alcon Vision LLCProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
96.2%Vascular Endothelial Growth Factor Inhibitor96.2%Aflibercept100%Part B, office-administered≥42 patientsSensory organs
3.8%Corticosteroid3.8%Prednisolone Acetate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
2 NIH research awards on record, funded 2010–2018 per NIH RePORTER. The latest:
- Wills Eye Community Intervention to Improve Glaucoma Detection and Follow-up Care
Wills Eye Health System
FY2018$600,000U01DP005127 - Wills Eye Community Intervention to Improve Glaucoma Detection and Follow-up Care
Wills Eye Health System
FY2017$600,000U01DP005127 - Wills Eye Community Intervention to Improve Glaucoma Detection and Follow-up Care
Wills Eye Health System
FY2016$600,000U01DP005127
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- [Persistent fatigue symptoms following COVID-19 infection in healthcare workers: risk factors and impact on quality of life].
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
Article2022 - [The Culturally Sensitive Therapy Relationship: A Concept for the Training and Further Education of Psychotherapists].
Psychotherapie, Psychosomatik, medizinische Psychologie
Article2020
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03Use of CT scans in selection of patients for pectusexcavatum surgery: A preliminary reportArticle720 citations1987
- 04
- 05Enzymatic Vitreolysis with Ocriplasmin for Vitreomacular Traction and Macular HolesArticle553 citations2012
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Teresa Horan, MD
Wills Eye Hospital
Allen Ho, MD
Wills Eye Hospital
Ralph Eagle, MD
Wills Eye Hospital
George Spaeth, MD
Wills Eye Hospital